BIO-TECHNE Corp (TECH) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-03-31..
Dividend safety
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 109.56M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-03-31 | (m) | $109.56M | (m) |
| 2025-12-31 | (m) | $81.10M | (m) |
| 2025-09-30 | (m) | $77.98M | (m) |
| 2025-06-30 | (m) | $73.40M | (m) |
| 2025-03-31 | (m) | $131.67M | (m) |
| 2024-12-31 | (m) | $158.14M | (m) |
| 2024-09-30 | (m) | $150.71M | (m) |
| 2024-06-30 | (m) | $168.10M | (m) |
| 2024-03-31 | (m) | $203.00M | (m) |
| 2023-12-31 | (m) | $224.16M | (m) |
| 2023-09-30 | (m) | $246.70M | (m) |
| 2023-06-30 | (m) | $285.26M | (m) |
| 2023-03-31 | (m) | $271.30M | (m) |
| 2022-12-31 | (m) | $261.82M | (m) |
| 2022-09-30 | (m) | $291.99M | (m) |
| 2022-06-30 | (m) | $272.05M | (m) |
| 2022-03-31 | (m) | $225.49M | (m) |
| 2021-12-31 | (m) | $210.53M | (m) |
| 2021-09-30 | (m) | $176.63M | (m) |
| 2021-06-30 | (m) | $140.41M | (m) |
| 2021-03-31 | (m) | $184.29M | (m) |
| 2020-12-31 | (m) | $174.95M | (m) |
| 2020-09-30 | (m) | $248.30M | (m) |
| 2020-06-30 | (m) | $229.30M | (m) |
| 2020-03-31 | (m) | $186.91M | (m) |
| 2019-12-31 | (m) | $195.13M | (m) |
| 2019-09-30 | (m) | $93.07M | (m) |
| 2019-06-30 | (m) | $96.07M | (m) |
| 2019-03-31 | (m) | $121.31M | (m) |
| 2018-12-31 | (m) | $96.40M | (m) |
| 2018-09-30 | (m) | $127.69M | (m) |
| 2018-06-30 | (m) | $126.15M | (m) |
| 2018-03-31 | (m) | $112.06M | (m) |
| 2017-12-31 | (m) | $114.49M | (m) |
| 2017-09-30 | (m) | $73.11M | (m) |
| 2017-06-30 | (m) | $76.09M | (m) |
| 2017-03-31 | (m) | $69.61M | (m) |
| 2016-12-31 | (m) | $78.51M | (m) |
| 2016-09-30 | (m) | $98.05M | (m) |
| 2016-06-30 | (m) | $104.48M | (m) |
| 2016-03-31 | (m) | $105.18M | (m) |
| 2015-12-31 | (m) | $99.18M | (m) |
| 2015-09-30 | (m) | $106.53M | (m) |
| 2015-06-30 | (m) | $107.73M | (m) |
| 2015-03-31 | (m) | $108.23M | (m) |
| 2014-12-31 | (m) | $115.58M | (m) |
| 2014-09-30 | (m) | $107.43M | (m) |
| 2014-06-30 | (m) | $110.95M | (m) |
| 2014-03-31 | (m) | $112.53M | (m) |
| 2013-12-31 | (m) | $114.01M | (m) |
| 2013-09-30 | (m) | $114.32M | (m) |
| 2013-06-30 | (m) | $112.56M | (m) |
| 2013-03-31 | (m) | $111.39M | (m) |
| 2012-12-31 | (m) | $110.03M | (m) |
| 2012-09-30 | (m) | $110.48M | (m) |
| 2012-06-30 | (m) | $112.33M | (m) |
| 2012-03-31 | (m) | $113.42M | (m) |
| 2011-12-31 | (m) | $112.73M | (m) |
| 2011-09-30 | (m) | $113.45M | (m) |
| 2011-06-30 | (m) | $112.30M | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | $109.78M | (m) |
| 2010-03-31 | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) |
| 2009-06-30 | (m) | $105.24M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |